OA10700A - Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. - Google Patents

Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. Download PDF

Info

Publication number
OA10700A
OA10700A OA9800087A OA9800087A OA10700A OA 10700 A OA10700 A OA 10700A OA 9800087 A OA9800087 A OA 9800087A OA 9800087 A OA9800087 A OA 9800087A OA 10700 A OA10700 A OA 10700A
Authority
OA
OAPI
Prior art keywords
carbon atoms
radical
atoms
hydrogen atom
alkyl
Prior art date
Application number
OA9800087A
Other languages
English (en)
French (fr)
Inventor
Herve Bouchard
Alain Commercon
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of OA10700A publication Critical patent/OA10700A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA9800087A 1995-12-22 1998-06-19 Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. OA10700A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
OA10700A true OA10700A (fr) 2002-11-27

Family

ID=9485871

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800087A OA10700A (fr) 1995-12-22 1998-06-19 Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.

Country Status (41)

Country Link
US (1) US5728849A (id)
EP (1) EP0876362B1 (id)
JP (1) JP3953106B2 (id)
KR (1) KR100500351B1 (id)
CN (1) CN1103766C (id)
AR (1) AR005197A1 (id)
AT (1) ATE250593T1 (id)
AU (1) AU712597B2 (id)
BG (1) BG63204B1 (id)
BR (1) BR9612135A (id)
CA (1) CA2238884C (id)
CO (1) CO4520184A1 (id)
CZ (1) CZ294972B6 (id)
DE (1) DE69630145T2 (id)
DK (1) DK0876362T3 (id)
DZ (1) DZ2149A1 (id)
EA (1) EA001533B1 (id)
ES (1) ES2202490T3 (id)
FR (1) FR2742751B1 (id)
HK (1) HK1017895A1 (id)
HU (1) HU225032B1 (id)
IL (1) IL124994A (id)
IN (4) IN186768B (id)
MA (1) MA26412A1 (id)
MX (1) MX9804688A (id)
MY (1) MY113934A (id)
NO (1) NO317358B1 (id)
NZ (1) NZ324337A (id)
OA (1) OA10700A (id)
PE (1) PE25198A1 (id)
PL (1) PL189311B1 (id)
PT (1) PT876362E (id)
RO (1) RO116194B1 (id)
SK (1) SK282835B6 (id)
TN (1) TNSN96169A1 (id)
TR (1) TR199801179T2 (id)
TW (1) TW371659B (id)
UA (1) UA48205C2 (id)
UY (1) UY24386A1 (id)
WO (1) WO1997023473A1 (id)
ZA (1) ZA9610737B (id)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
RU2264400C2 (ru) 2000-02-02 2005-11-20 Флорида Стейт Юниверсити Рисерч Фаундейшн, Инк. Таксан, фармацевтическая композиция на его основе и способ ингибирования роста опухоли
ATE353900T1 (de) * 2001-02-24 2007-03-15 Boehringer Ingelheim Pharma Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
CA2526278A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
CN102838599A (zh) 2006-05-04 2012-12-26 贝林格尔.英格海姆国际有限公司 多晶型
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
NZ600126A (en) * 2007-08-17 2013-12-20 Boehringer Ingelheim Int Purine derivatives for use in the treatment of fap-related diseases
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
AU2009281122C1 (en) * 2008-08-15 2016-04-21 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
AU2009290911A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en) 2008-12-23 2015-09-03 Boehringer Ingelheim International Gmbh Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR102668834B1 (ko) 2009-11-27 2024-05-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
ES2935300T3 (es) 2010-05-05 2023-03-03 Boehringer Ingelheim Int Combiterapia
KR20230051307A (ko) 2010-06-24 2023-04-17 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EA030121B1 (ru) 2011-07-15 2018-06-29 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные хиназолины, их получение и их применение в фармацевтических композициях
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2014080251A1 (en) 2012-11-24 2014-05-30 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
DK3122757T3 (da) 2014-02-28 2023-10-09 Hangzhou Dac Biotech Co Ltd Ladede linkere og anvendelse deraf til konjugering
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
JP6759326B2 (ja) 2015-07-12 2020-09-23 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． 細胞結合分子の共役のための架橋連結体
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin
AU2016429272A1 (en) 2016-11-14 2019-05-02 Hangzhou Dac Biotech Co., Ltd. Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
WO1993021173A1 (en) * 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them

Also Published As

Publication number Publication date
DZ2149A1 (fr) 2002-10-23
DK0876362T3 (da) 2004-02-02
ZA9610737B (en) 1997-06-27
ATE250593T1 (de) 2003-10-15
PE25198A1 (es) 1998-05-10
AU1180997A (en) 1997-07-17
IL124994A0 (en) 1999-01-26
MX9804688A (es) 1998-10-31
PL189311B1 (pl) 2005-07-29
IN188469B (id) 2002-09-28
SK282835B6 (sk) 2002-12-03
KR100500351B1 (ko) 2005-12-21
TW371659B (en) 1999-10-11
IL124994A (en) 2000-12-06
KR19990076680A (ko) 1999-10-15
EA001533B1 (ru) 2001-04-23
BR9612135A (pt) 1999-07-13
JP3953106B2 (ja) 2007-08-08
US5728849A (en) 1998-03-17
HUP9904046A3 (en) 2001-08-28
CN1103766C (zh) 2003-03-26
IN186768B (id) 2001-11-03
CN1205697A (zh) 1999-01-20
IN188470B (id) 2002-09-28
PT876362E (pt) 2004-02-27
CA2238884A1 (fr) 1997-07-03
BG102569A (en) 1999-04-30
NO982580D0 (no) 1998-06-05
UA48205C2 (uk) 2002-08-15
MY113934A (en) 2002-06-29
DE69630145D1 (de) 2003-10-30
UY24386A1 (es) 2001-08-27
AU712597B2 (en) 1999-11-11
CA2238884C (fr) 2007-02-06
WO1997023473A1 (fr) 1997-07-03
NO982580L (no) 1998-06-05
CO4520184A1 (es) 1997-10-15
NO317358B1 (no) 2004-10-18
CZ294972B6 (cs) 2005-04-13
EP0876362B1 (fr) 2003-09-24
IN188680B (id) 2002-10-26
FR2742751B1 (fr) 1998-01-30
HUP9904046A1 (hu) 2001-04-28
RO116194B1 (ro) 2000-11-30
MA26412A1 (fr) 2004-12-20
TNSN96169A1 (fr) 2005-03-15
FR2742751A1 (fr) 1997-06-27
JP2000502671A (ja) 2000-03-07
HU225032B1 (en) 2006-05-29
TR199801179T2 (xx) 1998-10-21
NZ324337A (en) 2000-03-27
SK85398A3 (en) 1998-11-04
BG63204B1 (bg) 2001-06-29
HK1017895A1 (en) 1999-12-03
CZ196198A3 (cs) 1998-09-16
DE69630145T2 (de) 2004-07-15
ES2202490T3 (es) 2004-04-01
AR005197A1 (es) 1999-04-14
EP0876362A1 (fr) 1998-11-11
EA199800588A1 (ru) 1998-12-24
PL327405A1 (en) 1998-12-07

Similar Documents

Publication Publication Date Title
EP0876362B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0817779B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0673372A1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0820448B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0885208B1 (fr) Taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2214322C (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0788492B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1995033736A1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0874838B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0764155B1 (fr) Taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2732341A1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2214320C (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2732340A1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1995033739A1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent